Cytarabine dose intensification improves survival in older patients with secondary/high-risk acute myeloid leukemia in matched real-world versus clinical trial data.

Abé, Christoph; Keto, Jaana; Lilja, Mathias; Konradsen, Mie; Mesterton, Johan; Höglund, Martin; Lazarevic, Vladimir; Lehmann, Sören; Juliusson, Gunnar

Abé, Christoph; Keto, Jaana; Lilja, Mathias; Konradsen, Mie; Mesterton, Johan; Höglund, Martin; Lazarevic, Vladimir; Lehmann, Sören; Juliusson, Gunnar.

Afiliação

Abé C; Quantify Research, Stockholm, Sweden.
Keto J; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Lilja M; Jazz Pharmaceuticals, Copenhagen, Denmark.
Konradsen M; Quantify Research, Stockholm, Sweden.
Mesterton J; Quantify Research, Copenhagen, Denmark.
Höglund M; Quantify Research, Stockholm, Sweden.
Lazarevic V; Medical Management Centre, Karolinska Institutet, Stockholm, Sweden.
Lehmann S; Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
Juliusson G; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund University, Lund, Sweden.